HTRF for high-throughput screening of HCMV NEC inhibitors. by Han Chen (228557)

“…The HTRF ratio for the NEC (signal, S) was ~3-fold higher than the background (B) HTRF ratios for His-UL50 or Myc-UL53 alone (S/B ~3). Untagged UL50 decreased S/B to near background levels, serving as a positive control, while UL50_E56A, which is highly defective for UL53 binding [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011781#ppat.1011781.ref012" target="_blank">12</a>] did not decrease S/B, serving as a negative control. …”

TPM1, TPM4, PCP4 and NPY are identified as having significantly increased abundance in the hippocampus after LDR exposure. by Diego Iacono (10785756)

Pharmacological α7 nAChR activation mediates spectrin breakdown. by Justin R. King (793933)

Comparison of <i>Killer-Rescue</i> and split <i>ClvR</i> genetics. by Georg Oberhofer (3401438)

Supplementary Material for: Five-Year Therapy with Recombinant Human Insulin-Like Growth Factor-1 in a Patient with PAPP-A2 Deficiency by Muthuvel G. (14430801)

“…We describe five-year treatment response to recombinant human IGF-1 (rhIGF-1) in a patient with PAPP-A2 deficiency, and the phenotype of PAPP-A2 deficiency in three siblings. …”

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Patterns in Species Persistence and Biomass Production in Soil Microcosms Recovering from a Disturbance Reject a Neutral Hypothesis for Bacterial Community Assembly by Fen-Guo Zhang (736948)

“…In microcosms recovering from the disturbance, however, species diversity decreased dramatically (by > 50%); and in most cases there was not a positive relationship between species initial abundance and their chance of persistence. …”

Time course of serum syndecan-1 concentration after admission. by Yuichiro Kitagawa (11174407)

“…<p>The concentration of syndecan-1 in serum was 72.4 ng/mL (95% confidence interval [CI], 37.5–107.2) at admission and peaked at 101.21 ng/mL (95% CI, 69.77–132.66) approximately 2.77 days after admission. …”

Gonadal development and sex ratios as a function of TL. by Frederic H. Martini (481487)

“…</p> <p>(b) Sex ratios (female:male) as a function of TL. Data were sorted into 50 mm TL intervals. …”

AzEvC10 mutant hypervirulence is caused by an RNase E mutation. by Mylene Vaillancourt (7409486)

Heatmaps with different genetic linkage and migration rate. by Georg Oberhofer (3401438)

“…<p>Heatmaps showing the average <i>Rescue</i> frequency for 100 <b>(A-C)</b> and 300 generations <b>(D-F)</b>. Linkage ranging from 0–50 cM, migration rate from 0.1–20% per generation. …”

A case of retroperitoneal fibrosis responding to steroid therapy by Ryuta Watanabe (4748580)

Mesenchymal stromal cells (MSCs) induce <i>ex vivo</i> proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) by Simone Perucca (3775696)

Peridomestic Infection as a Determining Factor of Dengue Transmission by Ruth Aralí Martínez-Vega (837538)

“…People cohabitating with IC or living within a 50-meter radius (exposed cohort) and subjects of areas with no ICs in a 200-meter radius (unexposed cohort) were included.…”

Introduction to Ecology; A study on hair colour and gender by Jenna Braun (2888243)

Imidazo[1,2-a]quinoxaline inhibits proliferation by Liyuan Luo (10997496)

“…Viabilities of LN229 and C6 cells was decreased to 24 and 29%, respectively on treatment with 50 μM IMQ. …”